Purinergic signalling in the pancreas in health and disease

J Endocrinol. 2012 May;213(2):123-41. doi: 10.1530/JOE-11-0434. Epub 2012 Mar 6.

Abstract

Pancreatic cells contain specialised stores for ATP. Purinergic receptors (P2 and P1) and ecto-nucleotidases are expressed in both endocrine and exocrine calls, as well as in stromal cells. The pancreas, especially the endocrine cells, were an early target for the actions of ATP. After the historical perspective of purinergic signalling in the pancreas, the focus of this review will be the physiological functions of purinergic signalling in the regulation of both endocrine and exocrine pancreas. Next, we will consider possible interaction between purinergic signalling and other regulatory systems and their relation to nutrient homeostasis and cell survival. The pancreas is an organ exhibiting several serious diseases - cystic fibrosis, pancreatitis, pancreatic cancer and diabetes - and some are associated with changes in life-style and are increasing in incidence. There is upcoming evidence for the role of purinergic signalling in the pathophysiology of the pancreas, and the new challenge is to understand how it is integrated with other pathological processes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • 5'-Nucleotidase / metabolism
  • Acinar Cells / physiology
  • Adenosine Triphosphate / physiology
  • Cystic Fibrosis / physiopathology
  • Diabetes Mellitus / physiopathology
  • Homeostasis
  • Humans
  • Insulin-Secreting Cells / physiology
  • Pancreas / innervation
  • Pancreas / physiology*
  • Pancreas / physiopathology*
  • Pancreas, Exocrine / physiopathology
  • Pancreatic Neoplasms / physiopathology
  • Pancreatic Stellate Cells / physiology
  • Pancreatitis / physiopathology
  • Receptors, Purinergic / physiology*
  • Signal Transduction / physiology

Substances

  • Receptors, Purinergic
  • Adenosine Triphosphate
  • 5'-Nucleotidase